265 related articles for article (PubMed ID: 19334485)
1. [How to raise efficacy of gastroesophageal reflux disease treatment].
Vakhrushev IaM; Potapova LO; Muravtseva OV
Ter Arkh; 2009; 81(2):27-30. PubMed ID: 19334485
[TBL] [Abstract][Full Text] [Related]
2. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients.
Weigt J; Kandulski A; Büsch F; Malfertheiner P
Dig Dis; 2009; 27(1):68-73. PubMed ID: 19439964
[TBL] [Abstract][Full Text] [Related]
3. Relationship of severity of gastroesophageal reflux disease with gastric acid secretory profile and esophageal acid exposure during nocturnal acid breakthrough: a study using 24-h dual-channel pH-metry.
Ghoshal UC; Chourasia D; Tripathi S; Misra A; Singh K
Scand J Gastroenterol; 2008; 43(6):654-61. PubMed ID: 18569981
[TBL] [Abstract][Full Text] [Related]
4. Does the presence of a hiatal hernia affect the efficacy of the reflux inhibitor baclofen during add-on therapy?
Beaumont H; Boeckxstaens GE
Am J Gastroenterol; 2009 Jul; 104(7):1764-71. PubMed ID: 19491837
[TBL] [Abstract][Full Text] [Related]
5. Control of esophageal and intragastric pH with compounded and manufactured omeprazole in patients with reflux esophagitis: a pilot study.
Moretzsohn LD; Carvalho EB; Franco JD; Soares MP; Brito EM; Belarmino K; Coelho LG
Can J Clin Pharmacol; 2009; 16(1):e264-72. PubMed ID: 19383986
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of symptomatic reflux episodes on Acid suppressive therapy.
Tutuian R; Vela MF; Hill EG; Mainie I; Agrawal A; Castell DO
Am J Gastroenterol; 2008 May; 103(5):1090-6. PubMed ID: 18445095
[TBL] [Abstract][Full Text] [Related]
7. A balancing view: Impedance-pH testing in gerd-limited role for now, perhaps more helpful in the future.
Shay S
Am J Gastroenterol; 2009 Nov; 104(11):2669-70. PubMed ID: 19888232
[No Abstract] [Full Text] [Related]
8. [Diagnosis and therapy of gastroesophageal reflux disease with lansoprazole].
Bordin DS; Masharova AA
Eksp Klin Gastroenterol; 2008; (5):85-90. PubMed ID: 19145922
[No Abstract] [Full Text] [Related]
9. Weakly acidic refluxes have a major role in the pathogenesis of proton pump inhibitor-resistant reflux oesophagitis.
Frazzoni M; Conigliaro R; Melotti G
Aliment Pharmacol Ther; 2011 Mar; 33(5):601-6. PubMed ID: 21198705
[TBL] [Abstract][Full Text] [Related]
10. Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough.
Mainie I; Tutuian R; Castell DO
J Clin Gastroenterol; 2008 Jul; 42(6):676-9. PubMed ID: 18496394
[TBL] [Abstract][Full Text] [Related]
11. [pH-impedancemetry: clinical implications].
Bertolini D; Roman S; Dumonceau JM
Rev Med Suisse; 2008 Sep; 4(169):1873-4, 1876-8. PubMed ID: 18831408
[TBL] [Abstract][Full Text] [Related]
12. [Role of psychological correction in the combination treatment of patients with gastroesophageal reflux disease].
Iurenev GL; Sirota NA; Dicheva DT; Bitkova EN; Maev IV
Ter Arkh; 2014; 86(8):42-9. PubMed ID: 25306743
[TBL] [Abstract][Full Text] [Related]
13. Esophageal acid exposure on proton pump inhibitors in unselected asymptomatic gastroesophageal reflux disease patients.
Grigolon A; Cantù P; Savojardo D; Conte D; Penagini R
J Clin Gastroenterol; 2008 Oct; 42(9):969-73. PubMed ID: 18719508
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy.
Sweis R; Anggiansah A; Wong T
Clin Gastroenterol Hepatol; 2010 Mar; 8(3):313. PubMed ID: 19788931
[No Abstract] [Full Text] [Related]
15. Reflux monitoring: pH-metry, Bilitec and oesophageal impedance measurements.
Pohl D; Tutuian R
Best Pract Res Clin Gastroenterol; 2009; 23(3):299-311. PubMed ID: 19505660
[TBL] [Abstract][Full Text] [Related]
16. Weakly acidic reflux.
Tack J; Blondeau K
Dig Dis; 2009; 27(1):58-61. PubMed ID: 19439962
[TBL] [Abstract][Full Text] [Related]
17. [Characteristics of gastroesophageal reflux disease in elderly people].
Masharova AA; Bordin DS
Eksp Klin Gastroenterol; 2007; (4):37-40. PubMed ID: 18411443
[No Abstract] [Full Text] [Related]
18. Medical therapy for gastroesophageal reflux disease in 2007.
Katz PO
Rev Gastroenterol Disord; 2007; 7(4):193-203. PubMed ID: 18192955
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy.
Pritchett JM; Aslam M; Slaughter JC; Ness RM; Garrett CG; Vaezi MF
Clin Gastroenterol Hepatol; 2009 Jul; 7(7):743-8. PubMed ID: 19281866
[TBL] [Abstract][Full Text] [Related]
20. Pro: Impedance testing is useful in the management of GERD.
Blondeau K; Tack J
Am J Gastroenterol; 2009 Nov; 104(11):2664-6. PubMed ID: 19888230
[No Abstract] [Full Text] [Related]
[Next] [New Search]
